Compare Pfizer Inc (PFE) vs Stanley Black & Decker, Inc. (SWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Stanley Black & Decker, Inc. — how do they compare? Pfizer Inc trades at $27.69 (market cap $158.56B), while Stanley Black & Decker, Inc. trades at $89.66 (market cap $13.47B). The key difference: Pfizer Inc is far larger — about 11.8× Stanley Black & Decker, Inc.'s market cap, and Pfizer Inc pays the higher dividend (6.18%). Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Stanley Black & Decker, Inc. for 62 Days on average.
| PFE | SWK | |
|---|---|---|
Market Cap | $158.56B | $13.47B |
Volume | 44,138,282 | 2,859,744 |
Sector | Health | Industrials |
52-Week High | $29.02 | $104.00 |
52-Week Low | $23.67 | $62.12 |
Typical Hold Time | 158 Days | 62 Days |
Enterprise Value | $210.06B | $17.63B |
Dividend Yield | 6.18% | 3.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
Stanley Black & Decker (SWK) trades at $88.31, down 1.87% with bearish technical signals. The company shows improving fundamentals with three consecutive quarterly EPS beats and projected 2026 net margin expansion to 4.06%. Recent product launches and margin improvement initiatives under CEO Chris Nelson provide positive catalysts. Valuation appears reasonable with P/E of 21.59 and P/S of 0.88.
SWK offers value with improving profitability and dividend stability, though technical weakness and competitive pressures present near-term risks. Analyst consensus at $93.00 suggests 5.3% upside potential. The stock's recovery depends on successful execution of margin improvement plans and sustained demand in industrial and automotive markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Stanley Black & Decker, Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →
